Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06292104 · ClinicalTrials.gov registry record
Phenotyping of Postural Orthostatic Tachycardia Syndrome (POTS)
A clinical trial of Postural Orthostatic Tachycardia Syndrome, sponsored by University of Texas Southwestern Medical Center.
- Recruiting
- Registry status
- 350
- Enrollment target
- 1
- Study location
NCT06292104: Recruiting study of Postural Orthostatic Tachycardia Syndrome, sponsored by University of Texas Southwestern Medical Center.
NCT06292104 is a study of Postural Orthostatic Tachycardia Syndrome that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 350 participants, below the 9,213-participant average among 11 other Postural Orthostatic Tachycardia Syndrome trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06292104, a study of Postural Orthostatic Tachycardia Syndrome, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.
- RECRUITING
- Registry status
- 350 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an observational study to deeply phenotype the disorder of POTS using multiple testing modalities.
Primary Outcome
Assignment of participant to a phenotypic group(s) based on analysis of multimodal data
Conditions Studied
Interventions
- DIAGNOSTIC_TEST multimodal diagnostic testing
Study Locations (1)
Texas
- UT Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2024-03-05 |
| Est. Completion | 2029-01 |
What NCT06292104 shows while recruiting
NCT06292104 is an observational study that tracks outcomes without assigning an intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, below the 9,213-participant average among 11 other Postural Orthostatic Tachycardia Syndrome trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Postural Orthostatic Tachycardia Syndrome appearing as the primary indexed condition, and to 1 intervention - of which multimodal diagnostic testing is the first listed.
NCT06292104 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06292104 about?
NCT06292104 is a clinical study titled "Phenotyping of Postural Orthostatic Tachycardia Syndrome (POTS)". This is an observational study to deeply phenotype the disorder of POTS using multiple testing modalities.
What is the current status of trial NCT06292104?
This trial is currently recruiting. The enrollment target is 350 participants. The study started on 2024-03-05. Estimated completion is 2029-01.
What conditions does trial NCT06292104 study?
This clinical trial studies the following conditions: Postural Orthostatic Tachycardia Syndrome.
What interventions are being tested in trial NCT06292104?
The interventions under investigation include: multimodal diagnostic testing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06292104?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06292104 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postural Orthostatic Tachycardia Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06292104's enrollment target sits among peer trials
350 2nd of 11 the highest of 11 other Postural Orthostatic Tachycardia Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Postural Orthostatic Tachycardia Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Auricular Vagal Nerve Stimulation for Hypermobile Ehlers-Danlos Syndrome
RECRUITING · NA
-
The Long COVID-19 Wearable Device Study
RECRUITING · NA
-
Assessment of Antibodies and Inflammatory Markers in Postural Tachycardia Syndrome
ACTIVE NOT RECRUITING
-
Evaluating the Prevalence of Acute Hepatic Porphyria in Postural Tachycardia Syndrome
ACTIVE NOT RECRUITING
-
Pathophysiology of Orthostatic Intolerance
ACTIVE NOT RECRUITING · NA
-
Transdermal Vagal Stimulation for POTS
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI